Bio Rad Laboratories reported $596.58M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Agilent A:US $ 1186M 73M
Becton, Dickinson and BDX:US $ 2558M 589M
Bio Rad Laboratories BIO:US $ 596.58M 205.73M
Bio Techne TECH:US $ 172.57M 11.75M
Bruker BRKR:US $ 723M 93.1M
Charles River Laboratories CRL:US $ 200.32M 41.55M
Danaher DHR:US $ 3984M 267M
Exact Sciences EXAS:US $ 56.2M 1.75M
Fluidigm FLDM:US $ 29.98M 1.53M
General Electric GE:US $ 13190M 348M
Hologic HOLX:US $ 2375.3M 84.5M
Illumina ILMN:US $ 1351M 119M
IQVIA Holdings Inc IQV:US $ 1.43B 41M
Laboratory Of America LH:US $ 1068.8M 164.7M
Mettler Toledo International MTD:US 109.45M 7.5M
Nanostring Technologies NSTG:US $ 126.03M 27.57M
Orasure Technologies OSUR:US $ 70.72M 46.04M
Pacific Biosciences Of California PACB:US $ 899.15M 470.58M
Perkinelmer PKI:US $ 360.86M 308.9M
Quest Diagnostics DGX:US $ 790M 78M
Repligen RGEN:US $ 596.51M 11.87M
Siemens SIE:GR € 9495M 2704M
Thermo Fisher Scientific TMO:US $ 1888M 864M
Tosoh 4042:JP Y 143948M 17568M
Waters WAT:US $ 419.79M 60.28M